Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Santhera Pharmaceuticals

Tracked across 6 events · 36 articles · First seen Apr 23, 2026 · Last active Aug 07, 2026

Sentiment
35
Attention
4
Events
6
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Regulatory
Impact: Santhera Pharmaceuticals will receive sales, milestone payments, and royalties from the net sales of AGAMREE in South Korea, Japan, Australia, and New Zealand due to the licensing agreement with Nxera Pharma The Orphan Drug Designation and Global Innovative Products on Fast Track designation for AGAMREE in South Korea are positive developments for the company.
Jun 02, 2026 · 6 articles
2 30
Business
Impact: Santhera expands its distribution network for AGAMREE, potentially increasing revenue and market access in Central Asia and the Caucasus.
Jul 13, 2026 · 6 articles
4 70
Tech
Impact: Santhera Pharmaceuticals is the developer of AGAMREE and benefits from positive clinical trial results, which could lead to expanded indications and increased sales-based milestone payments and royalties from its licensing partners.
Jul 01, 2026 · 6 articles
2 40
Business
Impact: Santhera signed a licensing agreement with Nxera for vamorolone in Japan, South Korea, Australia, and New Zealand, expanding access to a Duchenne Muscular Dystrophy treatment.
Aug 07, 2026 · 6 articles
2 0
Business
Apr 23, 2026 · 6 articles
2 0
Business
Apr 30, 2026 · 6 articles
Nxera Pharma licensor, investee ↔ Santhera Pharmaceuticals Santhera Pharmaceuticals is the licensor of vamorolone to Nxera Pharma for speci
Nxera Pharma licensee, investor ↔ Santhera Pharmaceuticals Nxera Pharma is a licensee of Santhera Pharmaceuticals, having acquired exclusiv
ERGEN INTELLIGENCE
Track Santhera Pharmaceuticals live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.